Join us for our 2nd annual webinar on June 22. We will be hosting Dr. Rudy Tanzi, who will present his latest findings in the field of Alzheimer’s disease genetic research. The presentation will include a brief history of Alzheimer’s disease research, an explanation of the Alzheimer’s Genome Project, as well as the introduction of his new research on abeta as an anti-microbial agent.

Click HERE to register.

If you are unable to attend the webinar, email us at [email protected] and we will send you a podcast of the event.

Dr. Rudy Tanzi is the Joseph P. and Rose F. Kennedy Professor of Neurology at the Harvard Medical School and the Director of the Genetics and Aging Research Unit at Massachusetts General Hospital. He has been investigating neurodegenerative disease since 1980 when he participated in the pioneering study that led to the location of the Huntington disease gene. He has identified several Alzheimer’s disease genes, including the first Alzheimer’s gene, the beta-amyloid protein precursor (APP). His work in the Alzheimer’s Genome Project, which has identified other new Alzheimer’s genes, was recognized by TIME magazine as one of the top 10 medical breakthroughs of 2008. Dr. Tanzi is a world-renowned leader in the studies of Alzheimer’s disease genetics.

The event will be held online, with each participant connecting through their own computer and telephone. More information on the webinar process can be found at www.gotowebinar.com

If you have any further questions, please contact us Katie Cutler at [email protected]